UiPath delivered better-than-expected quarterly results and still saw its stock fall roughly 16%.
That makes PATH one of the clearest examples of a larger software-market debate: when does artificial intelligence expand an existing software category, and when does it replace it?
For fiscal second-quarter 2027, UiPath reported $410 million in revenue, up 13% year over year.
Annual recurring revenue reached $1.938 billion, up 12%.
The company generated $37 million in net new ARR.
Non-GAAP gross margin was 82%.
UiPath also raised its full-year revenue forecast to approximately $1.789 billion–$1.794 billion.
Those numbers do not describe a collapsing business.
Yet investors sold the stock.
The reason is forward-looking competition.
Why did PATH fall?
Analysts remain unconvinced that UiPath will be one of the biggest winners from agentic AI.
The company built its business around robotic process automation.
RPA software automates repetitive business workflows.
But modern AI agents can increasingly interact with software, understand instructions and complete multistep tasks.
That creates a potential overlap.
If AI agents can perform work that once required specialized automation software, UiPath faces a threat.
If enterprises need UiPath to govern, orchestrate and secure those agents, AI becomes an opportunity.
The stock is trading on which scenario wins.
What did the quarter show?
The operating results were solid.
Revenue grew 13%.
ARR grew 12%.
Gross margin remained high.
The company was profitable on a GAAP operating basis.
Cash flow was positive.
Management said customer and partner momentum remained strong.
That shows UiPath still has a large installed base and a viable enterprise automation platform.
The debate is not about current survival.
It is about future acceleration.
Why is ARR growth so important?
ARR measures the recurring value of customer contracts.
Software investors use it as a forward indicator.
UiPath’s 12% ARR growth is respectable.
But the market wants to know whether AI can push that rate higher.
If agentic automation becomes a major new category, investors expect UiPath to participate.
If ARR remains around the low teens while AI adoption accelerates elsewhere, markets may conclude competitors are capturing more of the opportunity.
Who are the new competitors?
Traditional automation competitors still matter.
But the more important threat comes from major software platforms and AI model providers.
Salesforce, Microsoft and other enterprise-software companies are adding AI agents directly into their applications.
Anthropic and other model companies are also building deeper integrations with enterprise systems.
That can reduce the need for a separate automation layer in some workflows.
UiPath argues that complex enterprises still need orchestration.
A large company may use many systems, agents, robots and human approvals.
Managing all of that can require governance and integration.
That is UiPath’s strategic defense.
What is UiPath’s AI strategy?
The company increasingly describes its platform as a way to connect AI agents, software robots, business systems and people.
This is broader than classic RPA.
The goal is to become the control layer for enterprise automation.
That strategy makes sense.
The challenge is execution.
UiPath has to prove customers are buying the new capabilities in enough volume to reaccelerate ARR.
Why did some analysts downgrade the stock?
Because competitive pressure may be moving faster than reported financial metrics.
Current revenue can remain healthy even while future purchasing behavior changes.
That is common in enterprise software.
Customers do not cancel large platforms overnight.
The risk appears first in new deal sizes, expansion rates and pricing.
Analysts therefore look beyond one quarter’s revenue beat.
They want evidence that UiPath’s platform remains strategically necessary.
Is AI a tailwind or a threat?
It can be both.
AI is a tailwind if enterprises need more automation overall.
Every new AI agent can create additional workflows, permissions and governance requirements.
UiPath can help coordinate those systems.
AI is a threat if application vendors build automation natively into their own products.
In that scenario, customers may need fewer standalone tools.
The outcome likely differs by workflow.
Simple tasks may become commoditized.
Complex regulated workflows may still require dedicated orchestration.
Is the 16% decline justified?
The bearish view is that the market is correctly discounting structural competition.
The bullish view is that UiPath still grew revenue, raised guidance and maintains strong margins while transforming its platform.
If agentic AI increases overall automation demand, the company may eventually benefit.
The stock decline therefore reflects uncertainty more than immediate financial deterioration.
What should PATH investors watch next?
Watch ARR growth.
Watch net new ARR.
Watch dollar-based net retention.
Watch large enterprise deals.
Watch AI-agent product adoption.
Watch partnerships.
Watch competition from Salesforce, Microsoft and model providers.
And watch whether full-year guidance rises again.
The key conclusion is that UiPath’s earnings were not weak.
The stock fell because investors are asking a harder question:
Does AI make UiPath more necessary, or does it make parts of UiPath easier to replace?
That question will matter much more than any single quarterly beat.